Cargando…
XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
BACKGROUND: Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. The present treatment including surgery, chemotherapy and radiation, which have only 40% long-term cure rates, and usually cause tumor recurrence. Thus, looking for new effective and less toxic therapies has imp...
Autores principales: | Tian, Xiao-Hong, Hou, Wei-Jian, Fang, Yan, Fan, Jun, Tong, Hao, Bai, Shu-Ling, Chen, Qu, Xu, He, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866601/ https://www.ncbi.nlm.nih.gov/pubmed/24308762 http://dx.doi.org/10.1186/1756-9966-32-100 |
Ejemplares similares
-
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway
por: WU, XUEFANG, et al.
Publicado: (2016) -
Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2020) -
Author Correction: Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2021) -
Bioactivity Studies of Hesperidin and XAV939
por: Fazary, Ahmed E., et al.
Publicado: (2021) -
XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines
por: Renna, Cristiano, et al.
Publicado: (2015)